Ed Schoonveld is a Managing Principal at ZS Associates.
Going Beyond Lip Service on Value
June 22nd 2020Providing evidence for a strong value proposition to each of the access journey decision makers needs to be weighed against the risk of clinical trial failure, cost of investment, and launch timing. Ed Schoonveld outlines how a pharma company can analyze and rejuvenate its decision process.
Drug Price Controls: “Red Meat for the Left” or Russian Roulette?
September 18th 2015Kaiser’s August healthcare poll results should put all on high alert given public sentiment and the rhetoric of the political season. Ed Schoonveld sounds the alarm and offers four initiatives to stall the surge towards government intercession on escalating prices.